Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma.

Vinholt PJ, Overgaard M, Diederichsen AC, Mickley H, Poulsen TS, Sand NP, Nybo M, Rasmussen LM.

Thromb Res. 2013 May;131(5):396-400. doi: 10.1016/j.thromres.2013.03.001. Epub 2013 Mar 23.

PMID:
23531238
2.

Characterization of the interaction between von Willebrand factor and osteoprotegerin.

Shahbazi S, Lenting PJ, Fribourg C, Terraube V, Denis CV, Christophe OD.

J Thromb Haemost. 2007 Sep;5(9):1956-62.

4.

Measurement of von Willebrand factor-FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA-based assay in a reference laboratory.

Zhukov O, Popov J, Ramos R, Vause C, Ruden S, Sferruzza A, Dlott J, Sahud M.

Haemophilia. 2009 May;15(3):788-96. doi: 10.1111/j.1365-2516.2009.01995.x. Epub 2009 Feb 27.

PMID:
19298374
5.

Effect of unfractionated and low-molecular-weight heparin on OPG, sRANKL, and von Willebrand factor concentrations during hemodialysis.

Klejna K, Naumnik B, Koc-Żórawska E, Myśliwiec M.

Clin Appl Thromb Hemost. 2014 May;20(4):433-41. doi: 10.1177/1076029612463424. Epub 2012 Oct 26.

PMID:
23104956
6.

Application of an enzyme-linked immunosorbent assay (ELISA) to von Willebrand factor (vWF) and its derivatives.

Silveira AM, Yamamoto T, Adamson L, Hessel B, Blombäck B.

Thromb Res. 1986 Jul 1;43(1):91-102.

PMID:
2425450
7.

Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor.

Zannettino AC, Holding CA, Diamond P, Atkins GJ, Kostakis P, Farrugia A, Gamble J, To LB, Findlay DM, Haynes DR.

J Cell Physiol. 2005 Aug;204(2):714-23.

PMID:
15799029
8.

A sensitive ELISA for von Willebrand factor (vWf:Ag).

Ingerslev J.

Scand J Clin Lab Invest. 1987 Apr;47(2):143-9.

PMID:
3107116
9.

Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.

Flood VH, Gill JC, Morateck PA, Christopherson PA, Friedman KD, Haberichter SL, Hoffmann RG, Montgomery RR.

Blood. 2011 Feb 10;117(6):e67-74. doi: 10.1182/blood-2010-08-299016. Epub 2010 Dec 10.

11.
12.

Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.

Rutten B, Maseri A, Cianflone D, Laricchia A, Cristell NA, Durante A, Spartera M, Ancona F, Limite L, Hu D, Li H, Uren NG, de Groot PG, Mannucci PM, Roest M.

Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):64-74. doi: 10.1177/2048872614534388. Epub 2014 May 15.

PMID:
24833640
14.

[Application of collagen-binding assay for von Willebrand disease].

Zhou J, Jia YQ, Jiang H, Yang YM, Deng CQ.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Jan;35(1):126-9. Chinese.

PMID:
14981837
15.

High circulating osteoprotegerin levels are associated with non-zero blood groups.

Nagy EE, Varga-Fekete T, Puskas A, Kelemen P, Brassai Z, Szekeres-Csiki K, Gombos T, Csanyi MC, Harsfalvi J.

BMC Cardiovasc Disord. 2016 May 26;16(1):106. doi: 10.1186/s12872-016-0287-2.

16.
17.
18.

Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.

Veyradier A, Caron C, Ternisien C, Wolf M, Trossaert M, Fressinaud E, Goudemand J.

Haemophilia. 2011 Nov;17(6):944-51. doi: 10.1111/j.1365-2516.2011.02499.x. Epub 2011 Mar 3.

PMID:
21371195
19.

A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome.

Franchi F, Biguzzi E, Stufano F, Siboni SM, Baronciani L, Peyvandi F.

Thromb Res. 2014 Dec;134(6):1316-22. doi: 10.1016/j.thromres.2014.09.020. Epub 2014 Sep 28.

PMID:
25300810
20.

von Willebrand's disease: laboratory investigation using an improved functional assay for von Willebrand factor.

Favaloro EJ, Grispo L, Dinale A, Berndt M, Koutts J.

Pathology. 1993 Apr;25(2):152-8.

PMID:
8367196

Supplemental Content

Support Center